Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, INSMED INCORPORATED reported revenue of $606M, up 66.7% year over year. Operating margin was -205.6% and net margin -210.5%, on a free-cash-flow margin of -159.6% with capital expenditure at 5.4% of revenue. Every figure is computed directly from INSM's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $606M | -205.6% | -210.5% |
| FY2024 | $364M | -241.5% | -251.2% |
| FY2023 | $305M | -232.5% | -245.6% |
| FY2022 | $245M | -186.4% | -196.3% |
| FY2021 | $188M | -199.0% | -230.6% |
How does INSM compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AAWH · ABBV · ABCL · ABT · ABUS · ACAD
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.